Key Questions Answered in the Management of Follicular Lymphoma

Advances in the treatment of FL have led to the approval of two novel agents and updates to clinical practice guidelines. Nurses have unique and often long-standing relationships with their patients who have FL and are trusted sources of information and support. Oncology nurses who care for patients with FL should be aware of treatment guideline changes and their impact on clinical practice. Recently approved novel medications are associated with unique toxicities that differ from standard chemotherapy and more familiar regimens. As the healthcare providers most likely to see and manage toxicities, oncology nurses need education about these toxicities and their management in order to proactively mitigate potential issues and provide appropriate patient and caregiver education. Finally, the COVID-19 pandemic has impacted clinical practices in patients with FL and recommendations are updated as information becomes available. Oncology nursing professionals need to be able to educate patients about risk-reduction practices and treatment approaches that minimize their risk of COVID-19 infection.